Title Published Date
XCHC President & CEO, Robert Kane, Issues Cannabinoid Financial Industry Insight and Illustrates Possible Economic Impact to US Economy at Executive Breakfast Feb-28-2013
XCHC Invites Shareholders and Stakeholders to Amplify the February 25 Lobby Day Efforts of the Americans for Safe Access Unity Conference, Act by Contacting Your State and Federal Elected Officials Feb-26-2013
XCHC Releases Worldwide Growth Guidance For Its Cannabinoid Treatment Centers and Formulations Targeting Critical Human Ailments, Company Acts on Own Guidance Feb-21-2013
XCHC Gets Set to Launch its Cannabinoid Based Phytiva European Brand Product Line, Issues Positive Update on Internal Technology Upgrades and Marketing Developments Feb-21-2013
XCHC Provides Significant Operational Guidance on Maliseet Nation Partnership; Initial Planning Indicates 500-1000 Acres for Medical Cannabis Hospital Compound Comprised of Clinical Facilities, Clinical Research Labs, Organic Research, Dietary Programs Feb-19-2013
XCHC Appoints Maliseet Nation Councilor Gerald Bear to Facilitate Agreement with Maliseet Nation, Oversee the Development & Operations of the Medical Treatment Center, Clinical Laboratory, Manufacturing & Production Facility, and Cannabis Grow Facility Feb-15-2013
XCHC Signs Historic Agreement with WOLASTOKWIK NeGoot-Gook, Maliseet Nation at Tobique of Eastern Canada that Allows Medical Cannabis Hospitals, Laboratories, Clinics, for Cannabinoid Research & Treatments, Open to the World, All Full Compliance with Law Feb-13-2013
X-Change Corporation and Newly-Appointed Senior Medical Advisor Steven B. Hopping, M.D., F.A.C.S., Enter Discussions on Developing a High-End Skincare Product Line Feb-12-2013
Harvard-Trained Cosmetic Surgeon and Former President of the American Academy of Cosmetic Surgery, Steven B. Hopping, M.D., F.A.C.S., Appointed as Senior Medical Advisor of X-Change Corporation Feb-11-2013
X-Change Corp. Quickly Advances to Testing Stage with Its 'Phytiva' Brand of Products Jan-31-2013